Skip to main content
    P

    Profound Medical Corp (PROF)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $7.21
    +0.33 (+4.80%)

    Market Cap: $251.40M

    Last updated: Nov 06, 2026 at 4:42 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(18/40)
    Avg Surprise
    -0.16%

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$-0.15
    Range$-0.17 - $-0.13
    4 analysts
    Revenue Consensus
    $10M
    Range$8M - $13M
    5 analysts
    Last 12 of 40 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-0.15$-0.17 - $-0.13--4--
    Sep 26
    Reported Nov 5
    		$-0.21$-0.19$-0.22 - $-0.16-10.53%Miss4
    2
    0
    30d
    		+19.2%
    Jun 26
    Reported Aug 6
    		$0.26$-0.22$-0.29 - $-0.19+218.18%Beat4
    2
    2
    30d
    		+150.0%
    Mar 26
    Reported May 7
    		$-0.19$-0.25$-0.31 - $-0.23+24.00%Beat5
    1
    1
    30d
    		+47.2%
    Dec 25
    Reported Mar 5
    		$-0.27$-0.30$-0.33 - $-0.27+10.60%Beat3
    1
    0
    30d
    		-35.0%
    Sep 25
    Reported Nov 13
    		$-0.26$-0.38$-0.44 - $-0.32+31.58%Beat5
    2
    0
    30d
    		+31.6%
    Jun 25
    Reported Aug 14
    		$-0.52$-0.40$-0.47 - $-0.34-30.00%Miss4
    0
    1
    30d
    		-85.7%
    Mar 25
    Reported May 8
    		$-0.36$-0.28$-0.31 - $-0.26-28.57%Miss4
    0
    2
    30d
    		-38.5%
    Dec 24
    Reported Mar 6
    		$-0.20$-0.32$-0.39 - $-0.26+37.98%Beat4
    1
    1
    30d
    		+52.4%
    Sep 24
    Reported Nov 7
    		$-0.38$-0.30$-0.35 - $-0.26-26.67%Miss4
    No revisions (30d)
    		-46.2%
    Jun 24
    Reported Aug 8
    		$-0.28$-0.28$-0.34 - $-0.25+0.00%Beat4
    No revisions (30d)
    		+20.0%
    Mar 24
    Reported May 9
    		$-0.26$-0.31$-0.37 - $-0.26+16.13%Beat4
    No revisions (30d)
    		+18.8%
    Dec 23
    Reported Mar 7
    		$-0.42$-0.32$-0.40 - $-0.23-31.25%Miss7
    No revisions (30d)
    		+8.7%

    Key Metrics

    Valuation
    P/E Ratio-17.59EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-171.60%Operating Margin-445.70%
    ROE-73.50%ROIC-71.15%
    Financial Health
    Debt/Equity0.11xInterest CoverageN/A
    Current Ratio4.54xQuick Ratio3.70x
    Trading Statistics
    Beta0.56Avg Volume353.63K
    52-Week High$8.9552-Week Low$4.80

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.44
    SMA 20$6.32
    SMA 50$6.24
    SMA 200$6.65
    EMA 10$6.64
    EMA 20$6.42
    EMA 50$6.37
    EMA 200$6.51

    MACD

    Line: 0.20Signal: 0.05Hist: 0.15

    ADX

    ADX: 20.8+DI: 25.5-DI: 19.8

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down64.0
    PSAR$5.84

    Bollinger Bands

    Upper Band$7.55
    Lower Band$5.08
    %B Position3905%(Upper)
    Band Width0.86

    RSI (14-Day)

    Neutral
    64.4

    Momentum Oscillators

    Stoch %K85.1
    Stoch %D85.9
    Williams %R-9.3
    ROC (10d)29.7%
    Momentum1.65
    CCI (20d)70.2
    MFI (14d)56.4

    Volatility Measures

    ATR (14d)$0.47(6.6%)
    StdDev (20d)0.62
    Hist Vol69.9%(High)

    Volume Flow

    VWAP$6.86
    OBV3.9M
    AD Line1.4M
    CMF (20d)0.043

    Volume Metrics

    Avg Vol (20d)218.8K
    Vol Ratio1.5x
    VWMA (20d)$6.55

    Pivot Points

    R3$7.98
    R2$7.69
    R1$7.28
    Pivot Point$6.99
    S1$6.58
    S2$6.29
    S3$5.88

    Advanced Oscillators

    TSI13.14
    Ultimate Osc64.1
    KST37.28

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$9.83M$2.48M$5.34M$5.98M$5.29M$2.21M$2.62M$4.18M$2.83M$2.23M$1.44M$2.66M
    Cost of Revenue$2.15M$536,000$1.50M$1.99M$1.36M$593,000$768,000$1.21M$1.04M$812,000$573,000$1.35M
    Gross Profit$7.68M$1.95M$3.83M$3.99M$3.93M$1.62M$1.85M$2.96M$1.79M$1.42M$866,000$1.31M
    Operating Expenses$15.50M$13.01M$11.85M$11.36M$12.84M$15.42M$13.02M$11.31M$10.79M$9.26M$8.74M$65.55M
    R&D$5.81M$5.65M$5.26M$4.27M$5.42M$6.10M$4.81M$4.65M$4.17M$4.21M$3.94M$5.32M
    SG&A$9.70M$7.36M$6.59M$7.09M$7.43M$9.33M$8.21M$6.66M$6.62M$5.06M$4.80M$8.23M
    Operating Income$-7,821,000$-11,066,000$-8,021,000$-7,369,000$-8,913,000$-13,806,000$-11,166,000$-8,345,000$-8,998,000$-7,842,000$-7,877,000$-64,241,170
    Interest Income$196,000$336,000$377,000$160,000$122,000$343,000$445,000$332,000$220,000$422,000$462,000$1.37M
    Interest Expense$0$0$0$779,000$0$1.82M$0$0$190,000$0$0$343,231
    Income Before Tax$-7,726,000$-9,485,000$-7,028,000$-8,148,000$-7,856,000$-15,631,000$-10,683,000$-5,185,000$-9,188,000$-6,900,000$-6,545,000$-11,781,633
    Income Tax Expense$-4,000$55,000$25,000$26,000$121,000$64,000$41,000$-238,000$177,000$19,000$40,000$-303,418
    Net Income$-7,722,000$-9,540,000$-7,053,000$-8,174,000$-7,977,000$-15,695,000$-10,724,000$-4,947,000$-9,365,000$-6,919,000$-6,585,000$-11,478,215
    EBITDA$-7,789,000$-9,686,000$-7,305,000$-8,199,000$-7,831,000$-15,833,000$-10,965,000$-5,279,000$-9,194,000$-7,088,000$-6,757,000$-11,357,642
    EBIT$-7,922,000$-9,821,000$-7,405,000$-8,308,000$-7,978,000$-15,974,000$-11,128,000$-5,517,000$-9,408,000$-7,322,000$-7,007,000$-11,682,260
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PROF

    News

    Profound Medical Corp (PROF) (Q3 2026) Earnings Call Highlights: Revenue Surges 86% as Pipeline ...

    Profound Medical Corp (PROF) reported an 86% year-over-year revenue increase to $9.8 million in Q3 2026, with gross margins improving to 78%. Despite increased operating expenses and a continued net loss of $7.7 million...

    Yahoo Finance Singapore•11/5/26•Somewhat-Bullish

    Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth

    Profound Medical Corp. reported strong third-quarter 2026 financial results, including an 86% year-over-year revenue increase to $9.8 million and a gross margin of 78%. The company expanded its U.S. distribution through...

    Investing News Network•11/5/26•Bullish

    Profound Medical Announces Q3 2026 Net Loss of $7.7 Million with Revenue Surge to $9.83 Million

    Profound Medical Corp. reported a net loss of $7.7 million for Q3 2026, alongside a significant revenue increase to $9.83 million, up from $5.29 million in Q3 2025. Despite the revenue surge...

    Kalkine Media•11/4/26•Neutral

    The Technical Signals Behind (PROF) That Institutions Follow

    Profound Medical Corp. (NASDAQ: PROF) is showing divergent sentiment across various time horizons, indicating choppy market conditions. The article details three AI-generated trading strategies—Position Trading...

    Stock Traders Daily•11/2/26•Somewhat-Bullish

    Profound Medical (TSX:PRN) Signs a U.S. Distribution Deal With Cook Medical

    Profound Medical (TSX:PRN) has signed a U.S. supply and distribution agreement with Cook Medical's iMRI Division...

    Kalkine Media•11/2/26•Neutral

    PROF Valuation and Fair Value

    P/E
    -17.6x
    P/B
    6.2x
    See GNG's fair value

    PROF Profitability: Margins, ROIC and FCF

    Gross margin
    73.9%
    Operating margin
    -445.7%
    Net margin
    -171.6%
    ROIC
    -71.1%
    ROE
    -73.5%
    FCF margin
    -134.1%

    PROF Competitors

    CompanyTicker
    Spok Holdings IncSPOK
    High Tide IncHITI
    BioAge Labs, IncBIOA
    Lineage Cell Therapeutics IncLCTX
    QuantumSi IncQSI
    Bicycle Therapeutics LtdBCYC
    Anika Therapeutics IncANIK
    Standard Biotools IncLAB

    Sector: Healthcare

    PROF Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    0
    Buy
    5
    Hold
    0
    Sell
    0
    Strong Sell
    0

    PROF Bull Case vs Bear Case

    Bull case

    • PROF grew quarterly revenue 12.3% year over year.
    • 100.0% of PROF's analyst ratings are Buy or Strong Buy.

    Bear case

    • PROF has a -171.6% net profit margin.

    PROF Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    31.7%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $-0.15

    PROF Earnings Call

    The latest PROF earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    Frequently Asked Questions About PROF

    Does PROF pay dividends?

    Profound Medical Corp (PROF) does not currently pay a regular dividend.

    What is PROF's market cap?

    Profound Medical Corp (PROF) has a market capitalization of $251.40M with a current stock price of $7.21.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In